Related Experiment Videos
Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model
R Wagner1, J A DeLeo, D W Coombs
1Department of Pharmacology and Toxicology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.
Brain Research
|December 3, 1993
Summary
Spinal dynorphin, an opioid, increases after nerve injury. This study found higher dynorphin levels in rats exhibiting neuropathic pain behaviors, suggesting a role in pain signaling.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Increased spinal dynorphin levels are linked to hyperalgesia.
- Dynorphin is an endogenous opioid and kappa agonist.
Purpose of the Study:
- To investigate dynorphin expression in the spinal cord after sciatic cryoneurolysis (SCN).
- To correlate dynorphin levels with neuropathic pain behaviors like autotomy.
Main Methods:
- Sciatic cryoneurolysis (SCN) was used to induce a neuropathic pain model in rats.
- Immunohistochemistry was performed to detect dynorphin-like immunoreactivity (DLIR).
- Computer-assisted image analysis quantified DLIR in the spinal cord dorsal horns.
Main Results:
- Sciatic cryoneurolysis induced neuropathic pain behaviors including autotomy, allodynia, and spontaneous nociception.
- Dynorphin-like immunoreactivity (DLIR) was observed bilaterally in the spinal cord 21 days post-SCN.
- Significantly greater DLIR area was found in rats displaying autotomy compared to those without.
Conclusions:
- Spinal dynorphin levels increase following sciatic cryoneurolysis.
- The extent of dynorphin increase correlates with the severity of neuropathic pain behaviors.
- A bilateral increase in spinal dynorphin suggests a widespread role in neuropathic pain.